2025-2026 Regular Session • US Congress Legislature
HB3375
Legislative Summary
To require that the retail list price for certain prescription drugs and biological products may not exceed the average retail list price for the drug or biological product among certain nations.
Bill History
5/13/2025
Introduced in House
House of Representatives
5/13/2025
Referred to the House Committee on Energy and Commerce.
House of Representatives
Status Information
Current Status
Introduced(5/13/2025)
Chamber
House of Representatives
Committee
Energy And Commerce(House of Representatives)
Sponsors
Republican: 1
Primary Sponsor
Jeff Van Drew
Republican